Forecasts of cancer patients’ medical use (cancer type/cases). by Jinah Sim (15140709)

Subjects:

Number of admissions within 30 days by cancer type (2019 vs 2020). by Jinah Sim (15140709)

Subjects:

Relative percent change in billing charges related to medical use (2019 vs 2020). by Jinah Sim (15140709)

Subjects:

Forecasts of cancer patients’ medical use (cancer type/cases). by Jinah Sim (15140709)

Subjects:

Forecasts of cancer patients’ medical use (age/admission cases). by Jinah Sim (15140709)

Subjects:

The effect of utilization due the characters of cancer patients (income). by Jinah Sim (15140709)

Subjects:

The effect of utilization due the characters of cancer patients (age). by Jinah Sim (15140709)

Subjects:

Forecast of medical resource use and expenditures among cancer patients (2019 vs 2020). by Jinah Sim (15140709)

Subjects:

Relative percent change (%) in cancer incidence by cancer type (2019 vs 2020). by Jinah Sim (15140709)

Subjects:

The effect of utilization due the characters of cancer patients (sex). by Jinah Sim (15140709)

Subjects:

The effect of utilization due the characters of cancer patients (cancer type). by Jinah Sim (15140709)

Subjects:

Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

Subjects:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

Subjects:

S1 Dataset - by Naoya Itoh (6029276)

Subjects:

Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

Subjects: